Variant report
Variant | esv2752515 |
---|---|
Chromosome Location | chr13:64552802-64557199 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOS | chr13:64553954-64554516 | HUVEC | blood vessel: | n/a | chr13:64553991-64554000 |
2 | GATA2 | chr13:64553867-64554580 | HUVEC | blood vessel: | n/a | chr13:64554286-64554300 chr13:64554289-64554296 chr13:64554284-64554300 chr13:64554289-64554299 chr13:64554287-64554296 chr13:64553998-64554008 chr13:64554287-64554297 chr13:64554286-64554298 |
3 | GTF2F1 | chr13:64554185-64554213 | Hela-S3 | cervix: | n/a | n/a |
4 | JUN | chr13:64552636-64552846 | H1-hESC | embryonic stem cell: | n/a | chr13:64552775-64552787 chr13:64552832-64552841 |
5 | POLR2A | chr13:64557158-64557396 | K562 | blood: | n/a | n/a |
6 | POLR2A | chr13:64553885-64554446 | HUVEC | blood vessel: | n/a | n/a |
7 | POLR2A | chr13:64556005-64556911 | K562 | blood: | n/a | n/a |
8 | POLR2A | chr13:64555275-64555777 | K562 | blood: | n/a | n/a |
9 | POLR2A | chr13:64556839-64556957 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | POLR2A | chr13:64553889-64554161 | K562 | blood: | n/a | n/a |
11 | RCOR1 | chr13:64556126-64556128 | Hela-S3 | cervix: | n/a | n/a |
12 | STAT3 | chr13:64555557-64555614 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | TCF7L2 | chr13:64553050-64553261 | HEK293 | kidney: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
NFYAP1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1572350 | chr13:64552802-64552803 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs7993407 | chr13:64552805-64552806 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs7993570 | chr13:64552823-64552824 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs145531914 | chr13:64552825-64552826 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs77176191 | chr13:64552880-64552881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559315513 | chr13:64552906-64552907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527950008 | chr13:64552917-64552918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1414425 | chr13:64552919-64552920 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs570668497 | chr13:64552959-64552960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531776422 | chr13:64552962-64552963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550006609 | chr13:64552976-64552977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536184313 | chr13:64553079-64553080 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs535981499 | chr13:64553102-64553103 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs553848866 | chr13:64553120-64553121 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs73193319 | chr13:64553125-64553126 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs7995525 | chr13:64553149-64553150 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs558042914 | chr13:64553159-64553160 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs576446740 | chr13:64553174-64553175 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs558631012 | chr13:64553226-64553227 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs75075450 | chr13:64553260-64553261 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs7995728 | chr13:64553284-64553285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192023194 | chr13:64553304-64553305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148845301 | chr13:64553327-64553328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7994601 | chr13:64553341-64553342 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs181785211 | chr13:64553346-64553347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs117170402 | chr13:64553362-64553363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575156847 | chr13:64553363-64553364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555036836 | chr13:64553373-64553374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79795723 | chr13:64553385-64553386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564435591 | chr13:64553404-64553405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs563964231 | chr13:64553472-64553473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531908622 | chr13:64553522-64553523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549948098 | chr13:64553528-64553529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143470764 | chr13:64553560-64553561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs529344608 | chr13:64553581-64553582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185313373 | chr13:64553584-64553585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9592309 | chr13:64553599-64553600 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs539811383 | chr13:64553600-64553601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs9670703 | chr13:64553602-64553603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs4883727 | chr13:64553688-64553689 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs569948145 | chr13:64553705-64553706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9592310 | chr13:64553711-64553712 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs555571665 | chr13:64553719-64553720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs189828496 | chr13:64553752-64553753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540725412 | chr13:64553770-64553771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9317370 | chr13:64553782-64553783 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs577708188 | chr13:64553796-64553797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs370785870 | chr13:64553919-64553920 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs562980444 | chr13:64553978-64553979 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs113849579 | chr13:64554007-64554008 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:64552000-64553400 | Weak transcription | HUVEC | blood vessel |
2 | chr13:64553400-64558400 | Enhancers | HUVEC | blood vessel |
3 | chr13:64554000-64554800 | Enhancers | HepG2 | liver |